OP‑VISCHPMC Viscoelastic, ~5000 cps
The lower-viscosity HPMC in the Agaaz OVD line, built to spread, coat, and move through tissue planes with less resistance. Reach for it when the chamber needs flow, not just fill.
Chamber stability and
confident surgical flow.
OP‑VISC maintains anterior chamber depth, protects intraocular structures, and supports confident surgical manipulation, with a lower-viscosity feel built for spread and coating.
Chamber Maintenance
Maintains stable anterior chamber depth throughout surgical manoeuvres for confident, controlled procedures.
Consistent ~5000 cps Flow
Formulated at a lower working viscosity so it spreads and coats with less resistance through routine phacoemulsification steps.
Endothelial Protection
HPMC coats and protects the corneal endothelium during phacoemulsification and IOL implantation.
PFS Convenience
Prefilled syringe format eliminates preparation — ready for immediate, consistent delivery.
How HPMC viscoelastics
support cataract surgery.
HPMC-based OVDs are established anterior-segment surgical adjuncts that coat surfaces, maintain space, and protect tissue. OP‑VISC’s lower viscosity is formulated to favour spread and coating over maximum chamber firmness.
Chamber Injection
HPMC viscoelastic is injected into the anterior chamber, immediately creating a stable working space.
Surface Coating
Its lower-viscosity HPMC formulation is designed to coat the corneal endothelium and surrounding structures, forming a protective layer during phacoemulsification.
Space Maintenance
Maintains anterior chamber depth throughout the procedure, preventing collapse and supporting confident manipulation.
Easy Removal
At close of surgery, the viscoelastic is aspirated. HPMC is designed for straightforward removal from the anterior chamber.
Key parameters at a glance.
What the published literature says about hpmc viscoelastics in cataract surgery
The clinical case for this product category does not rest on our own material. The studies below are independent, peer-reviewed and indexed in PubMed, and they cover hpmc viscoelastics in cataract surgery as a subject. Each entry links to its PubMed record so the primary source can be read in full.
- Systematic ReviewSafety profile of long-term intraocular ophthalmic viscoelastic devices: a systematic reviewKhalil R et al. (2026) · The British journal of ophthalmology · PMID 41558833
- Randomized Controlled TrialA clinical comparison between DisCoVisc and 2% hydroxypropylmethylcellulose in phacoemulsification: a fellow eye studyEspíndola RF et al. (2012) · Clinics (Sao Paulo, Brazil) · PMID 23018304
- Randomized Controlled TrialIntraocular pressure after phacoemulsification using hydroxypropyl methylcellulose and sodium hyaluronate as viscoelasticsWaseem M et al. (2007) · Journal of Ayub Medical College, Abbottabad : JAMC · PMID 17867479
Independent peer-reviewed publications indexed in PubMed. Listed as clinical background on the molecule and device class; they are not studies of Agaaz products and imply no endorsement.
Common questions about
HPMC viscoelastics.
Ready to bring OP‑VISC
into your theatre?
~5000 cps HPMC in a ready-to-use prefilled syringe. Share your country and monthly volumes for pricing and documentation.